Karyopharm Therapeutics (KPTI) Insider Trading & Ownership $0.66 0.00 (-0.65%) (As of 12/18/2024 05:44 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Karyopharm Therapeutics (NASDAQ:KPTI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$1.45 M Get KPTI Insider Trade Alerts Want to know when executives and insiders are buying or selling Karyopharm Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address KPTI Insider Buying and Selling by Quarter Ad Porter & CompanyAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.I urge you to watch it now. Karyopharm Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/4/2024Richard A PaulsonCEOSell3,607$0.88$3,174.16 8/6/2024Richard A PaulsonCEOSell3,608$0.93$3,355.44 7/30/2024Stuart PoultonEVPSell2,883$1.06$3,055.98 7/5/2024Richard A PaulsonCEOSell3,616$0.85$3,073.60 6/7/2024Deepika PakianathanDirectorSell231,548$0.95$219,970.60 6/5/2024Deepika PakianathanDirectorSell468,044$0.96$449,322.24 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/4/2024Michael MasonCFOSell652$0.99$645.48 6/4/2024Richard A PaulsonCEOSell3,592$0.99$3,556.08 6/3/2024Deepika PakianathanDirectorSell360,744$1.00$360,744.00 5/31/2024Deepika PakianathanDirectorSell204,394$0.95$194,174.30 5/6/2024Richard A PaulsonCEOSell3,576$1.13$4,040.88 4/22/2024Reshma RangwalaEVPSell6,789$1.17$7,943.13 4/4/2024Richard A PaulsonCEOSell3,563$1.29$4,596.27 3/5/2024Richard A PaulsonCEOSell3,573$1.30$4,644.90 2/29/2024Michael ManoSVPSell16,973$1.17$19,858.41 2/29/2024Michael MasonCFOSell27,687$1.17$32,393.79 2/29/2024Reshma RangwalaEVPSell15,667$1.17$18,330.39 2/29/2024Richard A PaulsonCEOSell80,470$1.17$94,149.90 2/27/2024Michael MasonCFOSell2,545$1.32$3,359.40 2/15/2024Stuart PoultonEVPSell5,847$1.33$7,776.51 2/6/2024Michael MasonCFOSell4,205$1.59$6,685.95 2/6/2024Richard A PaulsonCEOSell4,012$1.59$6,379.08 1/4/2024Richard A PaulsonCEOSell4,114$0.82$3,373.48 (Data available from 1/1/2013 forward) KPTI Insider Trading Activity - Frequently Asked Questions Who is on Karyopharm Therapeutics's Insider Roster? The list of insiders at Karyopharm Therapeutics includes Deepika Pakianathan, Garen G Bohlin, Jatin Shah, Michael Kauffman, Michael Mano, Michael Mason, Reshma Rangwala, Richard A Paulson, Sharon Shacham, Sohanya Roshan Cheng, Stephen Mitchener, and Stuart Poulton. Learn more on insiders at KPTI. What percentage of Karyopharm Therapeutics stock is owned by insiders? 4.30% of Karyopharm Therapeutics stock is owned by insiders. Learn more on KPTI's insider holdings. Which Karyopharm Therapeutics insiders have been buying company stock? The following insider purchased KPTI shares in the last 24 months: Garen G Bohlin ($50,190.80). How much insider buying is happening at Karyopharm Therapeutics? Insiders have purchased a total of 41,140 KPTI shares in the last 24 months for a total of $50,190.80 bought. Which Karyopharm Therapeutics insiders have been selling company stock? The following insiders have sold KPTI shares in the last 24 months: Deepika Pakianathan ($1,224,211.14), Michael Mano ($25,029.45), Michael Mason ($86,230.06), Reshma Rangwala ($53,692.02), Richard A Paulson ($304,191.65), Sohanya Roshan Cheng ($48,237.77), Stephen Mitchener ($19,261.71), and Stuart Poulton ($34,391.10). How much insider selling is happening at Karyopharm Therapeutics? Insiders have sold a total of 1,591,889 Karyopharm Therapeutics shares in the last 24 months for a total of $1,795,244.90 sold. Karyopharm Therapeutics Key ExecutivesMr. Richard A. Paulson M.B.A. (Age 57)President, CEO & Director Compensation: $1.43M3 recent tradesMs. Sohanya Cheng M.B.A. (Age 41)Executive VP & Chief Commercial Officer Compensation: $742.95kMr. Stuart PoultonExecutive VP & Chief Development Officer1 recent tradesDr. Reshma Rangwala M.D. (Age 46)Ph.D., Executive VP, Chief Medical Officer & Head of Research Compensation: $777.32kDr. Mansoor Raza Mirza M.D. (Age 63)Clinical Consultant, Member of Scientific Advisory Board & Independent Director Compensation: $150kDr. Sharon Shacham M.B.A. (Age 54)Ph.D., Co-Founder & Chairman of Scientific Advisory Board Compensation: $1.4MMr. Cameron Peters (Age 64)Vice President of Finance, Assistant Treasurer & Principal Accounting Officer Ms. Elhan Webb C.F.A.Senior Vice President of Investor RelationsMr. Michael J. Mano J.D. (Age 47)Senior VP, General Counsel & Secretary Compensation: $625.08kMr. James Accumanno J.D.Chief Compliance Officer More Insider Trading Tools from MarketBeat Related Companies Acelyrin Insider Buying Trevi Therapeutics Insider Buying Eton Pharmaceuticals Insider Buying Canopy Growth Insider Buying Aquestive Therapeutics Insider Buying Tango Therapeutics Insider Buying Sage Therapeutics Insider Buying Jasper Therapeutics Insider Buying 4D Molecular Therapeutics Insider Buying C4 Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:KPTI) was last updated on 12/19/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karyopharm Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Karyopharm Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
